Patents by Inventor Viggo Kruse

Viggo Kruse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Determination of glycated (glycosylated) hemoglobin in blood
    Patent number: 5206144
    Abstract: The concentration of glycated hemoglobin, HbA.sub.1c, in hemoglobin from diabetic patients is regarded as a useful means of assessing the adequacy of diabetes control. This invention comprises a monoclonal antibody which, due to its specific binding of HbA.sub.1c, can be used for the determination of HbA.sub.1c in the absence of prior denaturation, in blood samples by such analytical methods as radioimmuno assay or enzyme-linked immunosorbent assay. The invention also comprises hybridoma cell lines which produce monoclonal antibodies of the invention.
    Type: Grant
    Filed: October 30, 1990
    Date of Patent: April 27, 1993
    Assignee: Novo Industri A/S
    Inventors: Jesper Zeuthen, Annette Prento, Viggo Kruse